Showing results (861-870 of 920) with videos related to
Sort By:
Pageof 92
Seminars in Arthritis and Rheumatism|November 13, 2022
Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaborationMegan Thomas, Deborah A Marshall, Adalberto Loyola Sanchez, et al.Clinical & Experimental Optometry|January 26, 2016
An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three yearsDuane R Geruschat, Thomas P Richards, Aries Arditi, et al.Annals of the Rheumatic Diseases|January 25, 2011
European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projectsM P T de Wit, S E Berlo, G J Aanerud, et al.Molecular and Cellular Biology|July 30, 2004
RPAP1, a novel human RNA polymerase II-associated protein affinity purified with recombinant wild-type and mutated polymerase subunitsCélia Jeronimo, Marie-France Langelier, Mahel Zeghouf, et al.Journal of Clinical Epidemiology|July 8, 2023
A multimethods randomized trial found that plain language versions improved parents' understanding of health recommendationsSarah A Elliott, Shannon D Scott, Rana Charide, et al.SLAS Discovery : Advancing Life Sciences R & D|November 9, 2019
Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical SpaceNoreen F Rizvi, John P Santa Maria, Ali Nahvi, et al.Research Involvement and Engagement|December 6, 2025
Patient engagement and shared decision-making in trial recruitment intervention studies: a systematic reviewTamara L Morgan, Natasha Hudek, Kelly Carroll, et al.Journal of Clinical Epidemiology|June 15, 2026
Protocol for a CONSORT extension for reporting Pragmatic and Explanatory trials designed using the PRECIS tool. (CONSORT-PRECIS)Jeremy Y Ng, Merrick Zwarenstein, Azadeh Barzideh, et al.Seminars in Arthritis and Rheumatism|June 22, 2025
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome DescriptorsN Raskin, M Hiligsmann, A R Rebutoc, et al.The Journal of Rheumatology|July 15, 2022
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic DrugsGlen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, et al.Pageof 92